EXORDIA Trademark

Trademark Overview

On Tuesday, September 5, 2017, a trademark application was filed for EXORDIA with the United States Patent and Trademark Office. The USPTO has given the EXORDIA trademark a serial number of 87595759. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 16, 2021. This trademark is owned by MonoSol Rx, LLC. The EXORDIA trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for treatment of sexual dysfunction; pharmaceutical preparations for prevention of sexual dysfunction; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, namely, pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; all of the foregoing excluding pharmaceutical preparations for the treatment of central nervous system and musculoskeletal diseases and disorders
exordia

General Information

Serial Number87595759
Word MarkEXORDIA
Filing DateTuesday, September 5, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 16, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements

Goods and ServicesPreparations for treatment of sexual dysfunction; pharmaceutical preparations for prevention of sexual dysfunction; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, namely, pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; all of the foregoing excluding pharmaceutical preparations for the treatment of central nervous system and musculoskeletal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWARREN, NJ 07059
Party NameMonoSol Rx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059
Party NameMonoSol Rx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Monday, August 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 16, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 29, 2020EXTENSION 5 GRANTED
Thursday, December 10, 2020EXTENSION 5 FILED
Tuesday, December 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 10, 2020TEAS EXTENSION RECEIVED
Friday, June 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2020EXTENSION 4 GRANTED
Wednesday, June 24, 2020EXTENSION 4 FILED
Wednesday, June 24, 2020TEAS EXTENSION RECEIVED
Tuesday, December 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 6, 2019EXTENSION 3 GRANTED
Friday, December 6, 2019EXTENSION 3 FILED
Friday, December 6, 2019TEAS EXTENSION RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 2 GRANTED
Monday, June 3, 2019EXTENSION 2 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Saturday, December 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018EXTENSION 1 GRANTED
Thursday, December 13, 2018EXTENSION 1 FILED
Thursday, December 13, 2018TEAS EXTENSION RECEIVED
Tuesday, July 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, May 27, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Saturday, April 14, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Saturday, April 14, 2018ASSIGNED TO PETITION STAFF
Wednesday, March 28, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 31, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 29, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 11, 2017ASSIGNED TO EXAMINER
Monday, September 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 8, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

exordia preparations treatment pharmaceutical diseases system disorders dysfunction sexual foregoing hyperplasia